KLRS Kalaris Therapeutics, Inc.

NASDAQ
$4.10

Kalaris Therapeutics, Inc. (KLRS) Institutional Ownership

What the institutions did with KLRS last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
68
filed a 13F this quarter
Managers holding
57
-1 on the quarter
Buyers
28
10 opened new
Sellers
20
11 sold out entirely
Buyer share
58.3%
of managers who traded it
Breadth
+16.7
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
SAMSARA BIOCAPITAL, LLC 12.9M 71.4%
RTW INVESTMENTS, LP 1.3M 7.2%
Alyeska Investment Group, L.P. 572.7K 3.2%
Siren, L.L.C. 435.8K 2.4%
VANGUARD CAPITAL MANAGEMENT LLC 398.7K 2.2%
Ikarian Capital, LLC 360.0K 2.0%
UBS Group AG 262.1K 1.5%
RENAISSANCE TECHNOLOGIES LLC 149.4K 0.8%
MARSHALL WACE, LLP 139.2K 0.8%
GEODE CAPITAL MANAGEMENT, LLC 114.0K 0.6%
Woodline Partners LP 100.0K 0.6%
ADAR1 Capital Management, LLC 100.0K 0.6%
WHI TRUST Co LLC 97.5K 0.5%
RAYMOND JAMES FINANCIAL INC 97.2K 0.5%
CITADEL ADVISORS LLC 95.8K 0.5%
BOOTHBAY FUND MANAGEMENT, LLC 92.3K 0.5%
Verdad Advisers, LP 80.3K 0.4%
MORGAN STANLEY 72.3K 0.4%
VANGUARD FIDUCIARY TRUST CO 66.2K 0.4%
BlackRock, Inc. 54.4K 0.3%
Belpointe Asset Management LLC 40.0K 0.2%
Fortis Capital Advisors, LLC 40.0K 0.2%
Pale Fire Capital SE 39.6K 0.2%
Squarepoint Ops LLC 38.8K 0.2%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32.5K 0.2%

Largest changes

Manager Action Previous Current Change
Paradigm Biocapital Advisors LP Sold Out 700.0K 0 -700.0K
Propel Bio Management, LLC Sold Out 295.8K 0 -295.8K
Kalehua Capital Management LLC Sold Out 271.2K 0 -271.2K
UBS Group AG Increased 6.2K 262.1K +255.9K
VANGUARD CAPITAL MANAGEMENT LLC Increased 255.3K 398.7K +143.4K
CITADEL ADVISORS LLC New 0 95.8K +95.8K
GOLDMAN SACHS GROUP INC Reduced 110.5K 16.1K -94.4K
Simplify Asset Management Inc. Sold Out 87.4K 0 -87.4K
RENAISSANCE TECHNOLOGIES LLC Increased 66.2K 149.4K +83.2K
Verdad Advisers, LP New 0 80.3K +80.3K
MARSHALL WACE, LLP Increased 67.9K 139.2K +71.3K
SAMSARA BIOCAPITAL, LLC Reduced 12.9M 12.9M -66.9K
MILLENNIUM MANAGEMENT LLC Sold Out 59.5K 0 -59.5K
683 Capital Management, LLC Sold Out 45.0K 0 -45.0K
Pale Fire Capital SE New 0 39.6K +39.6K
SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced 52.7K 14.2K -38.5K
MORGAN STANLEY Increased 38.3K 72.3K +34.0K
Trexquant Investment LP New 0 29.7K +29.7K
VANGUARD FIDUCIARY TRUST CO Increased 36.7K 66.2K +29.5K
GEODE CAPITAL MANAGEMENT, LLC Increased 87.5K 114.0K +26.5K
RAYMOND JAMES FINANCIAL INC Reduced 118.9K 97.2K -21.7K
BlackRock, Inc. Increased 36.0K 54.4K +18.4K
Quadrature Capital Ltd New 0 16.5K +16.5K
Connor, Clark & Lunn Investment Management Ltd. Increased 13.7K 30.0K +16.4K
DIMENSIONAL FUND ADVISORS LP New 0 16.0K +16.0K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.